Eurofins Scientific: Director/PDMR Shareholding
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts ERF Hot Sheet
Join SI Premium – FREE
LUXEMBOURG--(BUSINESS WIRE)-- Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM |
|||
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
a) |
Name |
Laurent Lebras |
|
2. |
Reason for the notification |
||
a) |
Position / status |
CFO |
|
b) |
Initial notification / amendment |
Initial |
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
Eurofins Scientific S.E. |
|
b) |
LEI |
529900JEHFM47DYY3S57 |
|
4. |
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Share |
|
|
Identification code |
ISIN: FR0014000MR3 |
|
b) |
Nature of the transaction |
Sale of shares |
|
Transaction is linked to the Eurofins stock option / free share / stock option program |
|||
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
EUR 82.50 |
1000 |
||
d) |
Aggregated information |
|
|
— Aggregated volume |
EUR 82,500.00 |
||
— Price |
EUR 82.50 |
||
e) |
Date of the transaction |
2026-10-22 |
|
g) |
Place of the transaction |
XPAR |
|
4. |
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Share |
|
|
Identification code |
ISIN: FR0014000MR3 |
|
b) |
Nature of the transaction |
Sale of shares |
|
Transaction is linked to the Eurofins stock option / free share / stock option program |
|||
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
EUR 81.50 |
500 |
||
d) |
Aggregated information |
|
|
— Aggregated volume |
EUR 40,750.00 |
||
— Price |
EUR 81.50 |
||
e) |
Date of the transaction |
2026-10-22 |
|
g) |
Place of the transaction |
XPAR |
|
4. |
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Share |
|
|
Identification code |
ISIN: FR0014000MR3 |
|
b) |
Nature of the transaction |
Exercise of stock options under the Eurofins stock option program. Number of options exercised: 1,000 |
|
Transaction is linked to the Eurofins stock option / free share / stock option program |
|||
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
N/A |
N/A |
||
d) |
Aggregated information |
|
|
— Aggregated volume |
N/A |
|
|
— Price |
N/A |
||
e) |
Date of the transaction |
2026-10-22 |
|
g) |
Place of the transaction |
XOFF |
|
4. |
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
|
||
a) |
Description of the financial instrument, type of instrument |
Share |
|
|
Identification code |
ISIN: FR0014000MR3 |
|
b) |
Nature of the transaction |
Sale of shares |
1,000 |
Transaction is linked to the Eurofins stock option / free share / stock option program |
|||
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
EUR 82.00 |
1,000 |
||
d) |
Aggregated information |
|
|
— Aggregated volume |
EUR 82,000.00 |
||
— Price |
EUR 82.00 |
||
e) |
Date of the transaction |
2026-10-22 |
|
g) |
Place of the transaction |
XPAR |
|
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM |
|||
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
a) |
Name |
Laurent Lebras |
|
2. |
Reason for the notification |
||
a) |
Position / status |
CFO |
|
b) |
Initial notification / amendment |
Initial |
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
Eurofins Scientific S.E. |
|
b) |
LEI |
529900JEHFM47DYY3S57 |
|
4. |
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Share |
|
|
Identification code |
ISIN: FR0014000MR3 |
|
b) |
Nature of the transaction |
Sale of shares |
|
Transaction is linked to the Eurofins stock option / free share / stock option program |
|||
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
EUR 84.00 |
1000 |
||
d) |
Aggregated information |
|
|
— Aggregated volume |
EUR 84,000.00 |
||
— Price |
EUR 84.00 |
||
e) |
Date of the transaction |
2026-10-23 |
|
g) |
Place of the transaction |
XPAR |
|
4. |
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Share |
|
|
Identification code |
ISIN: FR0014000MR3 |
|
b) |
Nature of the transaction |
Exercise of stock options under the Eurofins stock option program. Number of options exercised: |
2,000 |
Transaction is linked to the Eurofins stock option / free share / stock option program |
|||
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
n/a |
n/a |
||
d) |
Aggregated information |
|
|
— Aggregated volume |
n/a |
||
— Price |
n/a |
||
e) |
Date of the transaction |
2026-10-22 |
|
g) |
Place of the transaction |
XOFF |
|
4. |
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Share |
|
|
Identification code |
ISIN: FR0014000MR3 |
|
b) |
Nature of the transaction |
Sale of shares |
2,000 |
|
|
Transaction is linked to the Eurofins stock option / free share / stock option program |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
EUR 84.00 |
2,000 |
d) |
Aggregated information |
|
|
|
— Aggregated volume |
EUR 168,000.00 |
|
|
— Price |
EUR 84.00 |
|
e) |
Date of the transaction |
2026-10-23 |
|
g) |
Place of the transaction |
XPAR |
|
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With over 65,000 staff across a network of more than 950 laboratories in over 1,000 companies in 57 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261026704429/en/
For more information, please visit www.eurofins.com or contact:
Investor Relations
Eurofins Scientific SE
Phone: +32 2 766 1620
Source: Eurofins Scientific SE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UCSF Center for Reproductive Health and Conceivable Life Sciences Announce Collaboration and Plans for UCSF Fertility Excellence Center
- Four Rubin Rudman Partners Named to 2027 Lawdragon 500 Leading Dealmakers in America
- Vancity Selects Temenos SaaS to Modernize Core Banking
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
